NVX-CoV2705 is indicated for individuals aged 12 to 64 years with an underlying condition that poses high risk for severe COVID-19 outcomes.

Vaccine advisory panel, a frequent target of Kennedy, meets with little drama ACIP stresses importance of measles vaccination but mostly analyzed data on Covid, mpox, HPV The MMR vaccine.

On August 13, 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) declared the multi-country mpox outbreak a Public Health Emergency of Continental Security.1 Of concern is the ...

The World Health Organization Tuesday granted emergency use authorization for the second mpox vaccine. The LC16m8 vaccine from Japan's KM Biologics is the second since WHO declared mpox a health ...

The World Health Organization has authorized the first m-pox vaccine for children. It's a decision experts hope will help make immunizations more widely available to one of the hardest-hit ...

The World Health Organization (WHO) has approved the LC16m8 mpox vaccine for emergency use, marking it as the second vaccine to receive this status since the disease was declared a global health ...

The World Health Organization on Tuesday approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the second one to get the agency's seal of approval.

Maybe they didn’t get the full five-dose course in childhood. But combined with waning immunity from the acellular pertussis vaccine, we’ll see a much higher proportion of vaccinated individuals ...

In August 2024, WHO declared mpox a Public Health Emergency of International Concern for the second time in 2 years in response to a surge in cases driven by the novel clade I sublineage (Ib) in ...